TY - JOUR
T1 - Efficacy of a Chronic Care-Based Intervention on Secondary Stroke Prevention among Vulnerable Stroke Survivors
T2 - A Randomized Controlled Trial
AU - Cheng, Eric M.
AU - Cunningham, William E.
AU - Towfighi, Amytis
AU - Sanossian, Nerses
AU - Bryg, Robert J.
AU - Anderson, Thomas L.
AU - Barry, Frances
AU - Douglas, Susan M.
AU - Hudson, Lillie
AU - Ayala-Rivera, Monica
AU - Guterman, Jeffrey J.
AU - Gross-Schulman, Sandra
AU - Beanes, Sylvia
AU - Jones, Andrea S.
AU - Liu, Honghu
AU - Vickrey, Barbara G.
N1 - Funding Information:
This work was supported by an award from the American Heart Association Pharmaceutical Roundtable and David and Stevie Spina and by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number U54NS081764. Drs Cheng and Cunningham also received partial support from the UCLA/DREW Project EXPORT (National Center on Minority Health and Health Disparities grant numbers P20MD000148/P20MD000182). Dr Cunningham also receives partial support from the UCLA Center for Health Improvement of Minority Elderly/Resource Centers for Minority Aging Research (National Institute on Aging grant number P30AG021684).
Publisher Copyright:
© 2018 American Heart Association, Inc.
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Background: Disparities of care among stroke survivors are well documented. Effective interventions to improve recurrent stroke preventative care in vulnerable populations are lacking. Methods and Results: In a randomized controlled trial, we tested the efficacy of components of a chronic care model-based intervention versus usual care among 404 subjects having an ischemic stroke or transient ischemic attack within 90 days of enrollment and receiving care within the Los Angeles public healthcare system. Subjects had baseline systolic blood pressure (SBP) ≥120 mm Hg. The intervention included a nurse practitioner/physician assistant care manager, group clinics, self-management support, report cards, decision support, and ongoing care coordination. Outcomes were collected at 3, 8, and 12 months, analyzed as intention-to-treat, and used repeated-measures mixed-effects models. Change in SBP was the primary outcome. Low-density lipoprotein reduction, antithrombotic medication use, smoking cessation, and physical activity were secondary outcomes. Average age was 57 years; 18% were of black race; 69% were of Hispanic ethnicity. Mean baseline SBP was 150 mm Hg in both arms. SBP decreased to 17 mm Hg in the intervention arm and 14 mm Hg in the usual care arm; the between-arm difference was not significant (-3.6 mm Hg; 95% confidence interval, -9.2 to 2.2). Among secondary outcomes, the only significant difference was that persons in the intervention arm were more likely to lower their low-density lipoprotein <100 md/dL (2.0 odds ratio; 95% confidence interval, 1.1-3.5). Conclusions: This intervention did not improve SBP control beyond that attained in usual care among vulnerable stroke survivors. A community-centered component could strengthen the intervention impact. Clinical Trial Registration: URL: https://clinicaltrials.gov. Unique identifier: NCT00861081.
AB - Background: Disparities of care among stroke survivors are well documented. Effective interventions to improve recurrent stroke preventative care in vulnerable populations are lacking. Methods and Results: In a randomized controlled trial, we tested the efficacy of components of a chronic care model-based intervention versus usual care among 404 subjects having an ischemic stroke or transient ischemic attack within 90 days of enrollment and receiving care within the Los Angeles public healthcare system. Subjects had baseline systolic blood pressure (SBP) ≥120 mm Hg. The intervention included a nurse practitioner/physician assistant care manager, group clinics, self-management support, report cards, decision support, and ongoing care coordination. Outcomes were collected at 3, 8, and 12 months, analyzed as intention-to-treat, and used repeated-measures mixed-effects models. Change in SBP was the primary outcome. Low-density lipoprotein reduction, antithrombotic medication use, smoking cessation, and physical activity were secondary outcomes. Average age was 57 years; 18% were of black race; 69% were of Hispanic ethnicity. Mean baseline SBP was 150 mm Hg in both arms. SBP decreased to 17 mm Hg in the intervention arm and 14 mm Hg in the usual care arm; the between-arm difference was not significant (-3.6 mm Hg; 95% confidence interval, -9.2 to 2.2). Among secondary outcomes, the only significant difference was that persons in the intervention arm were more likely to lower their low-density lipoprotein <100 md/dL (2.0 odds ratio; 95% confidence interval, 1.1-3.5). Conclusions: This intervention did not improve SBP control beyond that attained in usual care among vulnerable stroke survivors. A community-centered component could strengthen the intervention impact. Clinical Trial Registration: URL: https://clinicaltrials.gov. Unique identifier: NCT00861081.
KW - blood pressure
KW - exercise
KW - risk factors
KW - secondary prevention
KW - stroke
UR - http://www.scopus.com/inward/record.url?scp=85047137116&partnerID=8YFLogxK
U2 - 10.1161/CIRCOUTCOMES.116.003228
DO - 10.1161/CIRCOUTCOMES.116.003228
M3 - Article
C2 - 29321134
AN - SCOPUS:85047137116
SN - 1941-7713
VL - 11
JO - Circulation: Cardiovascular Quality and Outcomes
JF - Circulation: Cardiovascular Quality and Outcomes
IS - 1
M1 - e003228
ER -